MANNATECH INC MTEX
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 1999-02-16
MANNATECH INC statistics & valuation
Market cap$9.8M
P / S0.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 74.9% | 77.6% | 78.0% | 75.9% | 78.6% |
| Operating margin | -0.4% | 1.2% | -0.7% | -0.3% | 5.7% |
| Net margin | -14.1% | 2.1% | -1.7% | -3.3% | 6.2% |
| FCF margin | -4.0% | 1.7% | -2.4% | -2.7% | 6.3% |
| Return on assets | -50.7% | 6.9% | -5.4% | -9.1% | 16.5% |
| Return on equity | 291.3% | 28.9% | -21.4% | -31.7% | 40.3% |
| Debt / equity | -0.53× | — | — | — | — |
| Current ratio | 1.10 | 1.25 | 1.07 | 1.17 | 1.42 |
| Revenue growth | -8.3% | -10.7% | -3.8% | -14.1% | 5.5% |
Source: SEC EDGAR filings · CIK 0001056358 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.